130 related articles for article (PubMed ID: 21404261)
21. Gene expression profile in a glioma cell line resistant to cell death induced by the chimeric tumor suppressor-1 (CTS-1), a dominant-positive variant of p53--the role of NFkappaB.
Seznec J; Weit S; Naumann U
Carcinogenesis; 2010 Mar; 31(3):411-8. PubMed ID: 20015865
[TBL] [Abstract][Full Text] [Related]
22. Engineering responsiveness to cell culture stresses: growth arrest and DNA damage gene 153 (GADD153) and the unfolded protein response (UPR) in NS0 myeloma cells.
Cudna RE; Dickson AJ
Biotechnol Bioeng; 2006 Jun; 94(3):514-21. PubMed ID: 16572396
[TBL] [Abstract][Full Text] [Related]
23. Defined protein-free NS0 myeloma cell cultures: stimulation of proliferation by conditioned medium factors.
Spens E; Häggström L
Biotechnol Prog; 2005; 21(1):87-95. PubMed ID: 15903244
[TBL] [Abstract][Full Text] [Related]
24. A single nutrient feed supports both chemically defined NS0 and CHO fed-batch processes: Improved productivity and lactate metabolism.
Ma N; Ellet J; Okediadi C; Hermes P; McCormick E; Casnocha S
Biotechnol Prog; 2009; 25(5):1353-63. PubMed ID: 19637321
[TBL] [Abstract][Full Text] [Related]
25. Chemostat-based transcriptional analysis of growth rate change and BCL-2 over-expression in NS0 cells.
Krampe B; Fagan A; Gaora PÓ; Al-Rubeai M
Biotechnol Bioeng; 2011 Jul; 108(7):1603-15. PubMed ID: 21337334
[TBL] [Abstract][Full Text] [Related]
26. Stability of recombinant protein production in the GS-NS0 expression system is unaffected by cryopreservation.
Barnes LM; Bentley CM; Dickson AJ
Biotechnol Prog; 2003; 19(1):233-7. PubMed ID: 12573031
[TBL] [Abstract][Full Text] [Related]
27. Proteomic analysis of enriched microsomal fractions from GS-NS0 murine myeloma cells with varying secreted recombinant monoclonal antibody productivities.
Alete DE; Racher AJ; Birch JR; Stansfield SH; James DC; Smales CM
Proteomics; 2005 Dec; 5(18):4689-704. PubMed ID: 16247733
[TBL] [Abstract][Full Text] [Related]
28. A high-yielding, generic fed-batch cell culture process for production of recombinant antibodies.
Sauer PW; Burky JE; Wesson MC; Sternard HD; Qu L
Biotechnol Bioeng; 2000 Mar; 67(5):585-97. PubMed ID: 10649233
[TBL] [Abstract][Full Text] [Related]
29. Targeting early apoptotic genes in batch and fed-batch CHO cell cultures.
Wong DC; Wong KT; Nissom PM; Heng CK; Yap MG
Biotechnol Bioeng; 2006 Oct; 95(3):350-61. PubMed ID: 16894638
[TBL] [Abstract][Full Text] [Related]
30. Cellular and transcriptomic analysis of NS0 cell response during exposure to hypoxia.
Swiderek H; Logan A; Al-Rubeai M
J Biotechnol; 2008 Mar; 134(1-2):103-11. PubMed ID: 18291545
[TBL] [Abstract][Full Text] [Related]
31. Expression of anti-apoptosis genes alters lactate metabolism of Chinese Hamster Ovary cells in culture.
Dorai H; Kyung YS; Ellis D; Kinney C; Lin C; Jan D; Moore G; Betenbaugh MJ
Biotechnol Bioeng; 2009 Jun; 103(3):592-608. PubMed ID: 19241388
[TBL] [Abstract][Full Text] [Related]
32. Enhanced productivity of NS0 cells in fed-batch culture with cholesterol nanoparticle supplementation.
Wu Y; Ma N; Wyslouzil BE; Chalmers JJ; McCormick E; Casnocha SA
Biotechnol Prog; 2011; 27(3):796-802. PubMed ID: 21509955
[TBL] [Abstract][Full Text] [Related]
33. Initial identification of low temperature and culture stage induction of miRNA expression in suspension CHO-K1 cells.
Gammell P; Barron N; Kumar N; Clynes M
J Biotechnol; 2007 Jun; 130(3):213-8. PubMed ID: 17570552
[TBL] [Abstract][Full Text] [Related]
34. Molecular portrait of high productivity in recombinant NS0 cells.
Seth G; Philp RJ; Lau A; Jiun KY; Yap M; Hu WS
Biotechnol Bioeng; 2007 Jul; 97(4):933-51. PubMed ID: 17149768
[TBL] [Abstract][Full Text] [Related]
35. Hyperosmotic stress in murine hybridoma cells: effects on antibody transcription, translation, posttranslational processing, and the cell cycle.
Sun Z; Zhou R; Liang S; McNeeley KM; Sharfstein ST
Biotechnol Prog; 2004; 20(2):576-89. PubMed ID: 15059005
[TBL] [Abstract][Full Text] [Related]
36. Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery.
De Angelis PM; Svendsrud DH; Kravik KL; Stokke T
Mol Cancer; 2006 May; 5():20. PubMed ID: 16709241
[TBL] [Abstract][Full Text] [Related]
37. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
Hamaï A; Richon C; Meslin F; Faure F; Kauffmann A; Lecluse Y; Jalil A; Larue L; Avril MF; Chouaib S; Mehrpour M
Oncogene; 2006 Dec; 25(58):7618-34. PubMed ID: 16983347
[TBL] [Abstract][Full Text] [Related]
38. Auditioning of CHO host cell lines using the artificial chromosome expression (ACE) technology.
Kennard ML; Goosney DL; Monteith D; Roe S; Fischer D; Mott J
Biotechnol Bioeng; 2009 Oct; 104(3):526-39. PubMed ID: 19544304
[TBL] [Abstract][Full Text] [Related]
39. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
40. Analysis of the role of GADD153 in the control of apoptosis in NS0 myeloma cells.
Lengwehasatit I; Dickson AJ
Biotechnol Bioeng; 2002 Dec; 80(7):719-30. PubMed ID: 12402318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
